384 results on '"Paggiaro, Pierluigi"'
Search Results
2. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
3. Severe Eosinophilic Asthma or Eosinophilic Granulomatosis With Polyangiitis: Potential Biomarkers for Novel Diagnostic Strategies
4. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus
5. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
6. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
7. Severe asthma: One disease and multiple definitions
8. Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms
9. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
10. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
11. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry
12. Phenotyping Occupational Asthma Caused by Acrylates in a Multicenter Cohort Study
13. Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
14. Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction
15. Severe Occupational Asthma: Insights From a Multicenter European Cohort
16. The Severe Asthma Network in Italy: Findings and Perspectives
17. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
18. Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice
19. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
20. The beclomethasone anti-inflammatory effect occurs in cell/mediator-dependent manner and is additively enhanced by formoterol: NFkB, p38, PKA analysis
21. Alpha1-antitrypsin deficiency and asthma
22. Work-related asthma in a sample of subjects with established asthma
23. Asthma management in a specialist setting: Results of an Italian Respiratory Society survey
24. Can the response to Omalizumab be influenced by treatment duration? A real-life study
25. Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
26. Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey.
27. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
28. Pirfenidone inhibits p38-mediated generation of procoagulant microparticles by human alveolar epithelial cells
29. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status
30. Asthma Control and Airway Inflammation in Patients with Eosinophilic Granulomatosis with Polyangiitis
31. Particulate matter induces prothrombotic microparticle shedding by human mononuclear and endothelial cells
32. The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial
33. Tiotropium inhibits proinflammatory microparticle generation by human bronchial and endothelial cells
34. Symptom versus exacerbation control: an evolution in GINA guidelines?
35. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
36. Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy
37. Potential benefit of omalizumab in respiratory diseases
38. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective
39. Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway
40. Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma
41. Effect of combination treatment on lung volumes and exercise endurance time in COPD
42. Are sputum eosinophils associated with a different phenotype in COPD patients? A retrospective study
43. Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization
44. Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry.
45. Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report
46. Assessing Exercise Performance during Exacerbations of Chronic Obstructive Pulmonary Disease: Work Smarter, not Harder!
47. Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease
48. A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes
49. Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study.
50. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.